Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

OCEA FINANCIAL STATEMENTS

Ocean Biomedical Inc. — balance sheet, income statement and cash flow trends

OCEAOcean Biomedical Inc.

🇺🇸 USA · PINK · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income
-150 M-100 M-50 M0202020212022202320242025

Profit Funnel

Q1 2025 · TTM
Revenue0 $Operating Income-4.2 M $ · -Infinity%Pre-tax Income-30.7 M $ · -Infinity%Net Income-30.7 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $—
Gross Profit——
Operating Income-4.2 M $—
EBITDA-29.7 M $—
Net Income-30.7 M $—

Peer Comparison· Biotechnology

CompanyRev. GrowthGross MarginEBITDA MarginNet Margin
OCEA————
Industry median5.1%84.0%-105.8%-125.7%

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
-100 M0100 M202020212022202320242025

Capital Structure

Q1 2025
Total Assets1.6 M
  • Current Liabilities26.6 M $28%
  • Long-term Liabilities67.4 M $72%

Key Figures

YoY change
Total Assets1.6 M $-46.3%
Total Liabilities94 M $+19.4%
Total Equity-92.4 M $—
Cash & ST Investments777 K $+3,989.5%
Total Debt9.4 M $-5.1%
Net Debt9.4 M $-5.0%

Peer Comparison· Biotechnology

CompanyCurrent RatioDebt/EquityNetDebt/EBITDAEquity/Assets
OCEA0.06-10.1%-0.29-5,840.6%
Industry median5.9010.9%1.1570.0%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-5 M0202020212022202320242025

Cash Flow Bridge

Q1 2025 · TTM
-4 M-2 M0-4.1 M $Operating4.3 M $Financing258 K $Net Change

Key Figures

YoY change
Operating Cash Flow-4.1 M $—
Capital Expenditures0 $—
Free Cash Flow-4.1 M $—
Dividends Paid——

Peer Comparison· Biotechnology

CompanyCF MarginFCF MarginCapEx RatioCF/Net Income
OCEA———13.2%
Industry median-88.0%-90.9%1.9%81.5%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on OCEA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.